SHARE
View printer-friendly versionA+A-

Press release

Printer Friendly Version View printer-friendly version
« Back
02/15/11
2010 Full-Year Results
 
 


2010 targets exceeded

Growth of over 20% in 2010 for Unimilk,
consolidated as from December 1, 2010

2011 targets: sales up 6 to 8%
with rises in free cash flow and operating margin


  • Danone sales[1] increased +6.9% in Q4 and in full year 2010[2]
  • Volume growth of +4.8% in Q4 and of +7.6% in full year 2010[2]
  • Trading operating margin[3] steady at 15.16% (+3 bps)[2] in 2010, up a steep +78 bps[2] in H2 compared with 2009
  • Underlying net income[3] up 14.2%[2]
  • Underlying fully-diluted Earnings Per Share [3] increased 8.6%[4] in reported figures to €2.71, rising 12.7% like-for-like
  • Free Cash Flow[3] up 20.0%[5] to €1,713 million
  • Proposal to pay a dividend of €1.30 per share

[1] Net sales
[2] Like for like see page 8 for definition
[3] See page 8 for details on calculation of financial indicators not defined in IFRS
[4] Theoretical ex-rights price (TERP) adjusted
[5] Reported figure

 

Chairman's comment

"Our sales grew by over 6% in 2010, rising from quarter to quarter, with volume and value both making positive contributions in the second half. All of our divisions and all our regions posted gains. Continued high operating margin and a 20% rise in free cash flow are remarkable achievements in a year that saw a steep rise in raw material prices and the end of adjustments to sales prices under our Reset Program, which improved our competitive edge. These robust performances in 2010 testify to the strength of our business model.

Reflecting the growth strategy Danone has pursued for many years, our structure is changing rapidly and emerging economies now represent half of our business. The joint venture uniting Danone and Unimilk since December,1,2010 makes Russia our largest single national market, with France. The move has created a new leader in Fresh Dairy products, with a nation-wide presence and strong brands in each segment. This investment offers exciting growth perspectives with major potential for value creation.

The strength of our Group, businesses, brands and teams, and our exposure to regions with robust growth prospects mean that we can look to 2011 with confidence. We anticipate no major change in consumer demand and in this context, also marked by persistently steep increases in raw material prices, we are placing the emphasis on lasting development of our brands, with a commitment to health, eating pleasure and respect for the environment. We will also be continuing efforts to raise global productivity to underpin our policy of competitive price management.

We will aim to outperform our competitors in organic sales growth, margin, and cash generation."

Financial highlights for 2010 (full year)

 

Key figures

2009

2010

Change

Sales[1] (€ m)

14 982

17 010

+6.9% [2]

Free cash flow[4](€ m)

1 427

1 713

+20.0% [3]

Trading operating income[4] (€ m)

2 294

2 578

+7.1% [2]

Trading operating margin

15.31%

15.16%

+3 bps [2]

Underlying net income[4] (€ m)

1 412

1 669

+14.2% [2]

Underlying fully diluted EPS[4](€ m)

2.50 [5]

2,71

+8.6% [3,5]

 

[1] Net sales
[2] Like for like see page 8 for definition
[3] Reported figures
[4] See page 8 for details on calculation of financial indicators not defined in IFRS
[5] TERP adjusted


Sales by business line and geographical area in Q4 and full-year 2010

 

€ m

Q4 09

Q4 10

Change
Like-for-like [1]

Volume growth
Like-for-like [1]

 

2009

2010

Change
Like-for-like [1]

Volume growth

Like-for-like [1]

BY BUSINESS LINE

 

 

 

 

 

 

 

 

 

Fresh Dairy

2 142

2 531

+6.2%

+3.3%

 

8 555

9 732

+6.5%

+7.5%

Waters

559

634

+5.2%

+7.3%

 

2 578

2 868

+5.3%

+7.8%

Baby Nutrition

735

856

+9.8%

+6.4%

 

2 924

3 355

+8.9%

+7.6%

Medical Nutrition

246

278

+7.7%

+8.4%

 

925

1 055

+9.0%

+8.7%

BY GEOGRAPHICAL AREA

 

 

 

 

 

 

 

 

 

Europe

2 185

2 388

+2.2%

+1.0%

 

8 960

9 449

+1.9%

+3.8%

Asia

453

588

+13.1%

+9.6%

 

1 877

2 386

+14.0%

+12.6%

Rest of World

1 044

1 323

+14.4%

+9.4%

 

4 145

5 175

+14.9%

+11.8%

 

 

 

 

 

 

 

 

 

 

Total

3 682

4 299

+6.9%

+4.8%

 

14 982

17 010

+6.9%

+7.6%

[1] See page 8 for details on calculation of financial indicators not defined in IFRS

Danone's Board of Directors met on February 14, 2011 to close statutory and consolidated financial statements for the 2010 fiscal year. The Company's auditors have largely completed their examination of accounts as of today.

Overview of 2010 sales

Consolidated sales rose 13.5% to €17,010 million in 2010. Excluding the impact of changes in exchange rates (+6.0%) and in scope of consolidation (+0.6%), total sales were up 6.9%. This organic growth reflects a +7.6% rise in sales volume and a -0.7% decrease due to price mix. Exchange-rate effects were due primarily to rises in the Brazilian real, the Mexican peso, the US dollar and the Russian ruble. Main changes in the scope of consolidation were the integration of Unimilk (Russia) from December 1, 2010, and, to a lesser extent, the arrival of two new European fruit-drink subsidiaries (Danone-Chiquita and Proviva), partially offset by the sale of Frucor (New Zealand) in February 2009.

Overview of sales performance – Q4 2010

Consolidated sales rose +16.8% to €4,299 million in the fourth quarter of 2010. Excluding exchange-rate effects (+6.7%) and changes in the scope of consolidation (+3.2%), the increase was +6.9%. This like-for-like rise reflects a +4.8% rise in sales volume and a 2.1% increase in sales value.

Fresh Dairy
Sales of the Fresh Dairy division increased by +6.2% on a like-for-like basis in the fourth quarter of 2010, reflecting volume growth of +3.3% and a 2.9% rise in value.

This takes into account a steep +27.1% like-for-like rise at Unimilk in December, reflecting volume growth of +8.9% and a significant rise in average price per kilo due to higher sales prices and improvement in value within the product mix.

Excluding the impact of Unimilk, Fresh Dairy sales continued the trend observed in the previous quarter, rising +5.4% like for like in the fourth quarter of 2010 with a combination of +2.8% volume growth and a positive price effect of +2.6%.

This performance illustrates continued momentum from the Reset program, despite a significantly higher basis for comparison in volume terms for the quarter and a persistently difficult consumer market in southern Europe.

The rise in sales price per kilo in the fourth quarter marks the end of the impact of the Reset program and a return to competitive management of the product portfolio and prices. Growth in sales value was affected by price rises in high-inflation countries (Argentina, Ukraine and Turkey), as well as Russia, where price increases were applied in line with overall market trends and also in response to an exceptional surge in milk prices due notably to adverse weather conditions in summer 2010.

The division's priority markets, among them the US, Russia and Brazil, continue to drive growth, while Activia is the division's most dynamic product, accounting for half of overall growth.

Water
The Waters division posted a +5.2% like-for-like rise in sales in the fourth quarter of 2010, in line with average growth over the year. A robust +7.3% rise in volumes confirms trends over the past six quarters, with continued double-digit growth in emerging markets and steadying volumes in mature economies, where France and German were top performers.

Baby Nutrition
The Baby Nutrition division turned in its best quarterly performance of the year, with sales up +9.8% like-for-like and volume growth reaching +6.4%. A +3.4% rise in value reflects a favorable geographical mix and price increases for infant milk in China, in line with market trends. All regions reported growth, with China, Indonesia and the United Kingdom still the main contributors. The milks category continued to deliver double-digit growth, while weaning foods saw a slight rise in the fourth quarter reflecting good performances in France, Poland and Russia.

Medical Nutrition
Medical Nutrition reported a +7.7% like-for-like sales growth in the fourth quarter of 2010, entirely attributable to a rise in volumes (+8.4%). Once again all regions contributed to growth, with Western Europe and new geographies contributing equally. All product categories gained ground, with pediatrics and the gastro-intestinal allergy range again showing above-average growth.

Steady trading operating margin in 2010 (like-for-like), up +3 bps overall on 2009

 

2009

2010

Change
Like-for-like [1]

BY BUSINESS LINE

 

 

 

Fresh Dairy

14.54%

14.03%

- 3 bps

 

Waters

12.56%

12.93%

+ 13 bps

 

Baby Nutrition

18.32%

18.92%

+ 17 bps

 

Medical Nutrition

20.57%

19.65%

- 62 bps

 

BY GEOGRAPHICAL AREA

 

 

 

Europe

16.04%

15.70%

- 1 bps

 

Asia

17.72%

18.66%

+ 63 bps

 

Rest of World

12.64%

12.55%

+ 1 bps

 

 

 

 

 

Total

15.31%

15.16%

+3 bps

 

[1] See page 8 for details on calculation of financial indicators not defined in IFRS

Danone's trading operating margin (EBIT) rose +3 bps to 15.16% in 2010, which saw a steep rise in raw material prices, particularly milk. The margin evolution was particularly favorable in the second half, with a +78 bps rise like-for-like compared to 2009.

The increase in raw materials was primarily offset by various cost-cutting measures that generated record savings of over €500 million during the year.

The benefits of a call for bids from media-space suppliers made in the end of 2009 for 2010 as a whole financed an increase of around 10% in media visibility for Group brands for a like-for-like rise in advertising expenses of only +6.8%. At the same time, promotional levels were gradually scaled back from particularly high levels during the Reset program in 2009, reducing total A&P as a percentage of sales by 93 bps (like-for-like).

Underlying net income attributable to the Parent rose +37.4% (reported figure). Underlying like-for-like fully diluted EPS increased by +8.6% to €2.71 in 2010

€ millions

2009

2010

Trading operating income

2 294

2 578

Other operating items

217

(80)

Operating income

2 511

2 498

Cost of net debt

(264)

(143)

Other financial items

(225)

134

Income tax

(424)

(576)

Net result of consolidated companies

1 598

1 913

Net result of affiliated companies

(77)

121

Net result

1 521

2 034

Attr to minority interests

160

164

Attr to the Parent
Parent

1 361

1 870

 

 

 

-/- non-current net result [1]

(51)

201

Underlying net income [1]

1 412

1 669

 

 

 

Underlying fully diluted EPS (€)1]

2.57

2.71

Underlying fully diluted EPS[1] (TERP-adjusted) (€)

2.50

-

[1] See page 8 for details on calculation of financial indicators not defined in IFRS

Cost of net debt fell sharply in 2010, due to the combined benefits of the June 2009 rights issue, debt restructuring, strong free cash flow generation and the proceeds of disposals of selected non-core activities.

The sharp rise in "Other financial income" resulted primarily from capital gains on the sale of a financial interest in Wimm Bill Dann (Russia). This accounted for most of the non-current net result.

The underlying tax rate [1] for the full year 2010 was 25.2%.

Underlying net income rose +18.2% in reported figure and +14.2% like-for-like to total €1,669 million. Underlying fully diluted EPS came to €2.71, showing a rise of +8.6% from the reported figure for 2009 and a 12.7% increase like-for-like.

Cash flow and Indebtedness

Cash flow
Free cash flow from operations increased 20.0% to €1,713 million, i.e 10.1% of sales in 2010, compared with 9.5% in 2009. Capital expenditure was €832 million, i.e 4.9% of sales.

Indebtedness
A combination of sound growth in free cash flow (net of dividends, share buybacks, acquisitions and the Unimilk transaction) enabled in 2010 a reduction of the net financial debt[1] by €278 million (excluding €3,858 million in put options granted to minority shareholders as of December 31, 2010) to €3,216 million.
[1] See page 8 for definition

2011 Outlook

Backed by steady growth at the end of the year, Danone is moving into 2011 with confidence. It expects 2010 trends to continue in the months ahead:

  • consumer spending in both the industrialized world and emerging economies shows no sign of either significant improvement or worsening;
  • raw material prices remain on a volatile upward path.


More specifically, in view of developments since the beginning of 2011, the Group expects total raw material and packaging costs to increase by 6 to 9% on average over the year, with a steeper increase in the first half reflecting the comparison with figures recorded in 2010.

Danone will be drawing on its experience of 2010 to manage these increases through consistently high productivity. The Group will also continue to use pricing to maintain competitive edge, benefiting from increased room for maneuver thanks to repositioning in 2009 (Reset program).

Another priority for 2011 will be the integration of Unimilk's operations in Russia and CIS countries, with sales and cost synergies set to boost Unimilk's operating margin from the second half on.

Altogether, targets for 2011 include:

  • a 6% to 8% rise in sales[1] on a like-for-like basis[2];
  • an increase of around 0.20% in trading operating margin[2], like-for-like. This will be fueled by all the Group's activities, but especially by Unimilk and synergies from its integration. As a result, the rise will only take shape in the second half, with first-half trading operating margin down slightly from the same period of 2010;
  • A rise in free cash flow [2] in keeping with the €2 billion target set for 2012.

[1] Net Sales
[2] See page 8 for details on calculation of financial indicators not defined in IFRS

Reduction of carbon footprint

Danone products depend to a large extent on natural eco-systems. It is therefore in the Group's best interest to take care for the environment as an integral part of its business activities.

Carbon footprint is a global indicator that reflects a wide range of environmental criteria. Danone is committed to reducing its carbon intensity (grams of CO2 per kilogram of product sold) by an ambitious -30% from 2008 to 2012.

In keeping with this commitment, Danone cut its carbon intensity by -22% [1] from 2008 to 2010. The Group is maintaining its 30% reduction target for 2012, i.e., over a five-year period.

[1] Based on constant scope and on emissions under Danone's direct responsibility (packaging, industrial activities, logistics and end of life)

Dividend

Danone will propose to the Annual General Meeting of Shareholders on Thursday, April 28, 2011, to approve distribution of a €1.30 dividend per share, to be paid in cash in respect of the 2010 fiscal year. This amount represents a +8.3% rise from 2009. The ex-dividend date will be Tuesday, May 10, 2011 and the dividend will be payable as from Friday, May 13, 2011.

Share buyback

Following receipt of income on disposal of non-strategic interests in Huiyuan and Wimm Bill Dann, Danone launched in October 2010 a share buyback for a total amount of €500 million. As of February 4, 2011, Danone purchased 9,180,100 shares for a total amount of €423 million.

Considering robust generation of free cash flow and assuming steady debt ratios, Danone plans to continue to buy back shares in the first half of 2011, up to a maximum of an additional €500 million.

Financial transactions and key developments in 2010 (from press releases issued during the quarter)

On October 28, Danone announced the finalization of the sale of its 18.4% stake in Wimm Bill Dann Foods for a received consideration of USD 470 million.

On November 17, Danone announced that it had successfully extended the maturity of its debt through a bond exchange offer for two tranches maturing in February 2014 and May 2015. As part of this transaction, Danone issued a new tranche of bonds for a nominal amount of €500 million, maturing in November 2020 with a 3.60% coupon, thus using favorable long-term interest rates to extend the average maturity of debt by one year.

On November 24, Danone signed an agreement to acquire YoCream, the leading producer of frozen yogurt in the United States, for around US$ 103 million. The acquisition rounds out Danone's existing distribution structure with a complementary away-from-home network, and expands the range of times and places where its products are consumed.

On November 25, Danone announced the appointment of Jordi Constans as Executive Vice President, Fresh Dairy Products, and Felix Martin as Executive Vice President, Baby Nutrition.

On November 30, Danone and Unimilk announced that they had finalized the merger of their fresh dairy product business in Russia and other CIS countries, creating the region's market leader in fresh dairy products.

On December 8, Danone announced that an opinion released the same day by EFSA (European Food Safety Agency) judged that the elements included in an application filed by Danone in 2009 were not sufficient to establish a definite relationship of cause and effect between the consumption of Actimel, containing L Casei DN114 001, and reduced risk of diarrhoea associated with Clostridium difficile bacteria in hospital environments.

o o O o o

Change in accounting method

In view of changes introduced for first-time application of IAS 27 (Revised), the Group has changed its method of accounting for put options granted to minority shareholders.

Starting January 1, 2010, the difference between the exercise price of put options granted to minority shareholders and the book value of these options is no longer accounted for by an increase in goodwill, but recognized into equity (excluding minorities).

To ensure consistent accounting for all similar transactions, the Group extended the scope of this change in method to cover put options granted prior to January 1, 2010 and not exercised at that date. As a result, goodwill corresponding to put options granted to minorities at December 31, 2009 has been reclassified, reducing equity by €2.7 billion.

The consolidated balance sheet for 2009 was restated to ensure comparability of figures for the 2009, 2010 and subsequent financial years.

This change in accounting method has no impact on the amount of net debt, since put options granted to minority shareholders remain classified as debt.

Financial indicators not defined in IFRS

Information published by Danone uses financial indicators that are not defined by IFRS. These are calculated as follows:

Like-for-like changes in net sales, trading operating income and trading operating margin exclude the impact of changes in (i) exchange rates, with both previous year and current year indicators calculated using the same exchange rates; and (ii) scope of consolidation, with previous year indicators calculated on the basis of current-year scope.

Trading operating income and expense is defined as the Group operating income excluding other operating income and expense. Other operating income and expense is defined under Recommendation 2009-R.03 of the French CNC, and comprises significant items that, because of their exceptional nature, cannot be viewed as inherent to current activities. These mainly include capital gains and losses on disposals of fully consolidated companies, impairment charges on goodwill, significant costs related to strategic restructuring and major acquisitions, and costs related to major litigation. Since application of IFRS 3 (Revised), they have also included acquisition fees related to business combinations.

Underlying net income or net income attributable to the Group measures the Group's recurring performance and excludes significant items that, because of their exceptional nature, cannot be viewed as inherent to the Group's current performance. Such non-current income and expense mainly include capital gains and losses on disposals and impairments of non fully-consolidated equity interests and tax income, and expense related to non-current income and expense. Non-current net income attributable to the Group is defined as non-current income and expense excluded from Net income attributable to the Group.

 

Year ended December 31

 

 

Year ended December 31

€ m

 

 

 

2009

 

 

 

 

 

2010

 

Current

Non current

 

Total

 

 

Current

Non current

 

Total

Trading operating income

2 294

 

 

2 294

 

 

2 578

 

 

2 578

Other operating income (expense)

 

217

 

217

 

 

 

(80)

 

(80)

Operating income

2 294

217

 

2 511

 

 

2 578

(80)

 

2 498

Cost of net debt

(264)

 

 

(264)

 

 

(143)

 

 

(143)

Other financial income (expense)

(120)

(105)

 

(225)

 

 

(91)

225

 

134

Net income before tax

1 910

112

 

2 022

 

 

2 344

145

 

2 489

Income tax

(448)

24

 

(424)

 

 

(590)

14

 

(576)

Net income from fully consolidated companies

1 462

136

 

1 598

 

 

1 754

159

 

1 913

Net income from affiliates

110

(187)

 

(77)

 

 

80

41

 

121

Net income

1 572

(51)

 

1 521

 

 

1 834

200

 

2 034

Attributable to the Parent

1 412

(51)

 

1 361

 

 

1 669

201

 

1 870

Attributable to non controlling interests

160

 

 

160

 

 

165

(1)

 

164

Free cash flow represents cash flows provided or used by operating activities less capital expenditure net of disposals and excluding acquisition costs related to business combinations (since the application of IFRS 3 (Revised)).

 

 

Year ended 31

€ m

2009

 

2010

 

Cash flows provided by (used in) operating activities

2 000

 

2 476

 

Capital expenditure

(699)

 

(832)

 

Disposal of tangible assets

126

 

44

 

Reverse of business combinations fees

 

 

25

 

Free cash flow

1 427

 

1 713

 

 

Net financial debt represents the net debt portion bearing interests. It corresponds to current and non current financial debt (i) excluding debt related to put options granted to non controlling interests (ii) net of cash and cash equivalents, marketable securities, other short term investments and assets components of financial instruments

Our presentation to analysts and investors will be broadcast live from 9.00 a.m. on Tuesday, February 15, 2010. Related slides will be available on our website (http://www.finance.danone.com/) from 7.30 a.m. today. 15, 2010, and the webcast can be downloaded thereafter."

o o O o o

FORWARD-LOOKING STATEMENTS

This press release contains certain forward-looking statements concerning DANONE. Although DANONE believes its
expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and
uncertainties, which could cause actual results to differ materially from those anticipated in these forward-looking
statements. For a detailed description of these risks and uncertainties, please refer to the section "Risk Factors" in
Danone's Annual Report (available on www.danone.com)

APPENDIX – Sales Overview

 

First Quarter

Second Quarter

Third Quarter

Fourth Quarter

Full Year

€ m

2009

2010

2009

2010

2009

2010

2009

2010

2009

2010

BY BUSINESS LINE

 

 

 

 

 

 

 

 

 

 

Fresh Dairy

2 121

2 319

2 141

2 436

2 151

2 446

2 142

2 531

8 555

9 732

Waters

614

620

735

828

670

786

559

634

2 578

2 868

Baby Nutrition

723

797

741

857

725

845

735

856

2 924

3 355

Medical Nutrition

216

242

229

265

234

270

246

278

925

1 055

BY GEOGRAPHICAL AREA

 

 

 

 

 

 

 

 

 

 

Europe

2 190

2 275

2 327

2 420

2 258

2 366

2 185

2 388

8 960

9 449

Asia

471

527

479

635

474

636

453

588

1 877

2 386

Rest of World

1 013

1 176

1 040

1 331

1 048

1 345

1 044

1 323

4 145

5 175

 

 

 

 

 

 

 

 

 

 

 

Group

3 674

3 978

3 846

4 386

3 780

4 347

3 682

4 299

14 982

17 010

 

First Quarter 2010

Second Quarter 2010

Third Quarter 2010

Fourth Quarter 2010

Full Year 2010

€ m

Reported Change

Like-for-like Change [1]

Reported Change

Like-for-like Change [1]

Reported Change

Like-for-like Change [1]

Reported Change

Like-for-like Change [1]

Reported Change

Like-for-like Change [1]

BY BUSINESS LINE

 

 

 

 

 

 

 

 

 

 

Fresh Dairy

9.4%

7.6%

13.8%

6.6%

13.7%

5.5%

18.1%

6.2%

13.8%

6.5%

Waters

1.0%

2.3%

12.5%

4.8%

17.4%

8.7%

13.4%

5.2%

11.3%

5.3%

Baby Nutrition

10.2%

8.5%

15.7%

8.7%

16.5%

8.6%

16.4%

9.8%

14.7%

8.9%

Medical Nutrition

11.8%

9.3%

16.0%

10.8%

15.0%

8.4%

13.3%

7.7%

14.0%

9.0%

BY GEOGRAPHICAL AREA

 

 

 

 

 

 

 

 

 

 

Europe

3.9%

2.1%

4.0%

1.4%

4.7%

2.1%

9.4%

2.2%

5.5%

1.9%

Asia

11.8%

12.2%

32.5%

15.3%

34.4%

15.3%

29.5%

13.1%

27.1%

14.0%

Rest of World

16.1%

16.1%

27.9%

15.9%

28.4%

13.5%

26.7%

14.4%

24.8%

14.9%

 

 

 

 

 

 

 

 

 

 

 

Group

8.3%

7.0%

14.0%

6.9%

15.0%

6.9%

16.8%

6.9%

13.5%

6.9%

[1] See page 8 for details on calculation of financial indicators not defined in IFRS